English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/72762
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Secreted phospholipase A2-IIA modulates key regulators of proliferation on astrocytoma cells

AuthorsMartín, Rubén ; Hernández, Marita ; Ibeas, Elvira ; Fuentes, Lucía ; Salicio, Veronica; Arnés, Mercedes ; Nieto, María Luisa
Issue Date2009
PublisherWiley-Blackwell
CitationJournal of Neurochemistry 111(4): 988-999 (2009)
AbstractHuman group IIA secreted phospholipase A2 (sPLA2-IIA) has been characterized in numerous inflammatory and neoplastic conditions. sPLA2-IIA can either promote or inhibit cell growth depending on the cellular type and the specific injury. We have previously demonstrated that exogenous sPLA2-IIA, by engagement to a membrane structure, induces proliferation and activation of mitogen-activated protein kinases cascade in human astrocytoma cells. In this study, we used human astrocytoma 1321N1 cells to investigate the key molecules mediating sPLA2-IIA-induced cell proliferation. We found that sPLA2-IIA promoted reactive oxygen species (ROS) accumulation, which was abrogated in the presence of allopurinol and DPI, but not by rotenone, discarding mitochondria as a ROS source. In addition, sPLA2-IIA triggered Ras and Raf-1 activation, with kinetics that paralleled ERK phosphorylation, and co-immunoprecipitation assays indicated an association between Ras, Raf-1 and ERK. Additionally, Akt, p70 ribosomal protein S6 kinase, and S6 ribosomal protein were also phosphorylated upon sPLA2-IIA treatment, effect that was abrogated by N-acetylcysteine or LY294002 treatment indicating that ROS and phosphatidylinositol 3 kinase are upstream signaling regulators. As the inhibitors N-acetylcysteine, PD98059, LY294002 or rapamycin blocked sPLA 2-IIA-induced proliferation without activation of the apoptotic program, we suggest that inhibition of these intracellular signal transduction elements may represent a mechanism of growth arrest. Our results reveal new potential targets for therapeutic intervention in neuroinflammatory disorders and brain cancer in particular. © 2009 International Society for Neurochemistry.
URIhttp://hdl.handle.net/10261/72762
DOI10.1111/j.1471-4159.2009.06377.x
Identifiersdoi: 10.1111/j.1471-4159.2009.06377.x
issn: 0022-3042
e-issn: 1471-4159
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
Jneurochem_Nieto_2009.pdf584,25 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.